Adherus Autospray Dural Sealant
Device Craniomaxillofacial
PDI 00897146002018
General payments
$156,786
Research payments
$1,541,753
Through program year 2025, $156,786 in general payments and $1,541,753 in research payments were reported against Adherus Autospray Dural Sealant (Craniomaxillofacial).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
9 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $35,863 | 286 |
| 2024 | General | $42,203 | 327 |
| 2024 | Research | $645,223 | 7 |
| 2023 | General | $34,075 | 265 |
| 2023 | Research | $820,759 | 23 |
| 2022 | General | $27,718 | 269 |
| 2022 | Research | $43,709 | 3 |
| 2021 | General | $16,926 | 129 |
| 2021 | Research | $32,061 | 1 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 26 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 33 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
1,276 general · 34 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.